Zosuquidar

SI-6212

Zosuquidar, >98% (HPLC)

CAS No. : [167354-41-8]

Synonyms : RS-33295-198; LY-335979

IUPAC Name : (R)-1-(4-((1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c][7]annulen-6-yl)piperazin-1-yl)-3-(quinolin-5-yloxy)propan-2-ol

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Zosuquidar inhibits P‑gp with nanomolar potency (K_i = 59 nM), improving intracellular drug accumulation and overcoming efflux‑mediated resistance. It shows antitumor effects and is an important tool compound for AML research.

References : Dantzig A. H. et al.: Cancer Res., 56(18), 4171-9, 1996; Tang R. et al.: BMC Cancer, 8, 51, 2008; Cripe D. L. et al.: Blood, 116(20), 4077-85, 2010.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.